acute myeloid leukemia

News
Venetoclax Plus Gilteritinib Shows High Rates of mCRC in Patients with AML
07/19/2021
Venetoclax combined with gilteritinib demonstrates high mCRC rates and antileukemic activity in patients with FLT3-mutated relapsed or refractory (R/R) acute myeloid leukemia (AML) in an updated phase 1b study.
Venetoclax combined with gilteritinib demonstrates high mCRC rates and antileukemic activity in patients with FLT3-mutated relapsed or refractory (R/R) acute myeloid leukemia (AML) in an updated phase 1b study.
Venetoclax combined with...
07/19/2021
Oncology
Real-World Treatment Patterns, FLT3 Testing, and Outcomes in AML
Videos
Real-World Treatment Patterns, FLT3 Testing, and Outcomes in AML
01/14/2021
Amer Zeidan, MBBS, MHS, discusses results from a retrospective study examining FLT3 testing trends, treatment patterns, and overall survival in relapsed/refractory AML.
Amer Zeidan, MBBS, MHS, discusses results from a retrospective study examining FLT3 testing trends, treatment patterns, and overall survival in relapsed/refractory AML.
Amer Zeidan, MBBS, MHS,...
01/14/2021
Journal of Clinical Pathways
Diagnostic Dilemmas
An Atypical Chronic Ulcer Caused by Acute Myeloid Leukemia
04/12/2019
Atypical chronic wounds are challenging for clinicians because of their identification, diagnosis, and treatment. These wounds may reflect an underlying systemic or malignant disease; therefore, an accurate diagnosis and initiation of the...
Atypical chronic wounds are challenging for clinicians because of their identification, diagnosis, and treatment. These wounds may reflect an underlying systemic or malignant disease; therefore, an accurate diagnosis and initiation of the...
Atypical chronic wounds are...
04/12/2019
Wounds
Perspectives
The Evolution of Care for Acute Myeloid Leukemia and the Challenges of Defining Value
05/21/2018
Abstract: Adult acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. Distinct subtypes of AML have been defined based on morphology, immunophenotyping, and molecular genetics. AML usually progresses...
Abstract: Adult acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. Distinct subtypes of AML have been defined based on morphology, immunophenotyping, and molecular genetics. AML usually progresses...
...
05/21/2018
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use